56558-0 |
Aldosterone^10M post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Aldosterone [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/dL |
|
|
|
|
|
|
CHAL |
|
56558-0 |
|
|
|
|
Observation |
|
|
|
0 |
Aldost 10M p chal SerPl-mCnc |
|
|
|
N |
|
10M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.34 |
2.29 |
|
|
|
|
|
|
|
ng/dL |
|
|
|
0 |
56559-8 |
Norepinephrine^pre/post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Norepinephrine [Mass/volume] in Serum or Plasma --pre/post XXX challenge |
|
DEL |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
CHAL |
|
56559-8 |
|
|
|
|
Observation |
|
|
|
0 |
Deprecated Norepineph pre/p chal SerPl-m |
|
|
|
N |
|
After; Before; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.36 |
2.29 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
5656-4 |
Gold |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Gold [Mass/volume] in Blood |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
DRUG/TOX |
|
5656-4 |
|
|
|
|
Both |
|
|
|
0 |
Gold Bld-mCnc |
|
|
|
Y |
|
AU; Blood; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
56560-6 |
Somatotropin^4.5H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --4.5 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
56560-6 |
|
|
|
|
Observation |
|
|
|
0 |
GH 4.5h p chal SerPl-mCnc |
|
|
|
N |
|
270 min; 4 1/2 hours; 4.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.4 |
2.29 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
56561-4 |
Somatotropin^5.5H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --5.5 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
56561-4 |
|
|
|
|
Observation |
|
|
|
0 |
GH 5.5h p chal SerPl-mCnc |
|
|
|
N |
|
5.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.4 |
2.29 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
56562-2 |
Somatotropin^6.5H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --6.5 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
56562-2 |
|
|
|
|
Observation |
|
|
|
0 |
GH 6.5h p chal SerPl-mCnc |
|
|
|
N |
|
6.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.4 |
2.29 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
56563-0 |
Somatotropin^7.5H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
56563-0 |
|
|
|
|
Observation |
|
|
|
0 |
GH 7.5h p chal SerPl-mCnc |
|
|
|
N |
|
7.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.4 |
2.29 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
56564-8 |
Somatotropin^8H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --8 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
56564-8 |
|
|
|
|
Observation |
|
|
|
0 |
GH 8h p chal SerPl-mCnc |
|
|
|
N |
|
8h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.4 |
2.29 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
56565-5 |
Somatotropin^9H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --9 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
56565-5 |
|
|
|
|
Observation |
|
|
|
0 |
GH 9h p chal SerPl-mCnc |
|
|
|
N |
|
9h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.4 |
2.29 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
56566-3 |
Somatotropin^9.5H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --9.5 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
56566-3 |
|
|
|
|
Observation |
|
|
|
0 |
GH 9.5h p chal SerPl-mCnc |
|
|
|
N |
|
9.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.4 |
2.29 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
56567-1 |
Somatotropin^10H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --10 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
56567-1 |
|
|
|
|
Observation |
|
|
|
0 |
GH 10h p chal SerPl-mCnc |
|
|
|
N |
|
10h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.4 |
2.29 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
56568-9 |
Somatotropin^10.5H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --10.5 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
56568-9 |
|
|
|
|
Observation |
|
|
|
0 |
GH 10.5h p chal SerPl-mCnc |
|
|
|
N |
|
10.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.4 |
2.29 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
56569-7 |
Somatotropin^11H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --11 hour post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
56569-7 |
|
|
|
|
Observation |
|
|
|
0 |
GH 11h p chal SerPl-mCnc |
|
|
|
N |
|
11h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.4 |
2.29 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
5657-2 |
Gold |
MCnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Gold [Mass/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
DRUG/TOX |
|
5657-2 |
|
|
|
|
Both |
|
|
|
0 |
Gold CSF-mCnc |
|
|
|
Y |
|
AU; Cerebral spinal fluid; Cerebrospinal Fl; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.42 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
56570-5 |
Somatotropin^11.5H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --11.5 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
56570-5 |
|
|
|
|
Observation |
|
|
|
0 |
GH 11.5h p chal SerPl-mCnc |
|
|
|
N |
|
11.5h p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.4 |
2.29 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
56571-3 |
Somatotropin^post exercise |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --post exercise |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
56571-3 |
|
|
|
|
Observation |
|
|
|
0 |
GH p Exc SerPl-mCnc |
|
|
|
N |
|
After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; EXCZ; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p Exc; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.4 |
2.29 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
56572-1 |
Somatotropin^20H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Somatotropin [Mass/volume] in Serum or Plasma --20 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ug/L;ng/mL |
|
|
|
|
|
|
CHAL |
|
56572-1 |
|
|
|
|
Observation |
|
|
|
0 |
GH 20H p chal SerPl-mCnc |
|
|
|
N |
|
20H p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; GH; Growth hormone; HGH; Human growth hormone; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH |
2.4 |
2.29 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
56573-9 |
Renin^30M post XXX challenge |
CCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Renin [Enzymatic activity/volume] in Plasma --30 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/mL/h |
|
|
|
|
|
|
CHAL |
|
56573-9 |
|
|
|
|
Observation |
|
|
|
0 |
Renin 30M p chal Plas-cCnc |
|
|
|
N |
|
30M p chal; Active renin; After; Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; Catalytic Concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Heart Disease; Kidney; Nephrology; p chal; Pl; Plasma; Plasma renin activity; Plsm; Point in time; PRA; PST; QNT; Quan; Quant; Quantitative; Random; Renal |
2.42 |
2.29 |
|
|
|
|
|
|
|
ng/mL/h |
|
|
|
0 |
56574-7 |
Renin^1H post XXX challenge |
CCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Renin [Enzymatic activity/volume] in Plasma --1 hour post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/mL/h |
|
|
|
|
|
|
CHAL |
|
56574-7 |
|
|
|
|
Observation |
|
|
|
0 |
Renin 1h p chal Plas-cCnc |
|
|
|
N |
|
1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; Active renin; After; Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; Catalytic Concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Heart Disease; Kidney; Nephrology; p chal; Pl; Plasma; Plasma renin activity; Plsm; Point in time; PRA; PST; QNT; Quan; Quant; Quantitative; Random; Renal |
2.42 |
2.29 |
|
|
|
|
|
|
|
ng/mL/h |
|
|
|
0 |
56575-4 |
17-Hydroxyprogesterone^15M post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/dL |
|
|
|
|
|
|
CHAL |
|
56575-4 |
|
|
|
|
Observation |
|
|
|
0 |
17OHP 15M p chal SerPl-mCnc |
|
|
|
N |
|
15M p chal; 17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.34 |
2.29 |
|
|
|
|
|
|
|
ng/dL |
|
|
|
0 |
56576-2 |
17-Hydroxyprogesterone^45M post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/dL |
|
|
|
|
|
|
CHAL |
|
56576-2 |
|
|
|
|
Observation |
|
|
|
0 |
17OHP 45M p chal SerPl-mCnc |
|
|
|
N |
|
17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; 45M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Genetics; Heredity; Heritable; Hydroxyproges; Hydroxyprogstron; Inherited; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.34 |
2.29 |
|
|
|
|
|
|
|
ng/dL |
|
|
|
0 |
56577-0 |
Renin^1.5H post XXX challenge |
CCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Renin [Enzymatic activity/volume] in Plasma --1.5 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/mL/h |
|
|
|
|
|
|
CHAL |
|
56577-0 |
|
|
|
|
Both |
|
|
|
0 |
Renin 1.5h p chal Plas-cCnc |
|
|
|
N |
|
1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; Active renin; After; Angiotensin forming enzyme; Angiotensinogenase; Cardio; Cardiology; Catalytic Concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Heart Disease; Kidney; Nephrology; p chal; Pl; Plasma; Plasma renin activity; Plsm; Point in time; PRA; PST; QNT; Quan; Quant; Quantitative; Random; Renal |
2.42 |
2.29 |
|
|
|
|
|
|
|
ng/mL/h |
|
|
|
0 |
56578-8 |
Aldosterone^1.5H post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Aldosterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/dL |
|
|
|
|
|
|
CHAL |
|
56578-8 |
|
|
|
|
Observation |
|
|
|
0 |
Aldost 1.5h p chal SerPl-mCnc |
|
|
|
N |
|
1 1/2 hours; 1 1/2 HR; 1.5h p chal; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.34 |
2.29 |
|
|
|
|
|
|
|
ng/dL |
|
|
|
0 |
56579-6 |
Aldosterone^20M post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Aldosterone [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
ng/dL |
|
|
|
|
|
|
CHAL |
|
56579-6 |
|
|
|
|
Observation |
|
|
|
0 |
Aldost 20M p chal SerPl-mCnc |
|
|
|
N |
|
20M p chal; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.34 |
2.29 |
|
|
|
|
|
|
|
ng/dL |
|
|
|
0 |
5658-0 |
Gold |
MCnt |
Hair |
Pt |
Qn |
|
|
ACTIVE |
Gold [Mass/mass] in Hair |
|
MIN |
DefinitionDescription |
|
|
mg/kg |
|
|
|
|
|
|
DRUG/TOX |
|
5658-0 |
|
|
|
|
Both |
|
|
|
0 |
Gold Hair-mCnt |
|
|
|
Y |
|
AU; DRUG/TOXICOLOGY; Drugs; Har; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.42 |
1 |
|
|
|
|
|
|
|
mg/kg |
|
|
|
0 |